-
1
-
-
0036109031
-
Multivariate meta-analysis of controlled drug studies for obsessive-compulsive disorder
-
DOI 10.1097/00004714-200206000-00012
-
Ackerman DL, Greenland S (2002). Multivariate meta-analysis of controlled drug studies for obsessive-compulsive disorder. J Clin Psychopharmacol 22: 309-317. (Pubitemid 34546847)
-
(2002)
Journal of Clinical Psychopharmacology
, vol.22
, Issue.3
, pp. 309-317
-
-
Ackerman, D.L.1
Greenland, S.2
-
3
-
-
0034177434
-
Selective serotonin reuptake inhibitors versus tricyclic antidepressants: A meta-analysis of efficacy and tolerability
-
DOI 10.1016/S0165-0327(99)00092-0, PII S0165032799000920
-
Anderson IM (2000). Selective serotonin reuptake inhibitors versus tricyclic antidepressants: A meta-analysis of efficacy and tolerability. J Affect Disord 58:19-36. (Pubitemid 30173208)
-
(2000)
Journal of Affective Disorders
, vol.58
, Issue.1
, pp. 19-36
-
-
Anderson, I.M.1
-
4
-
-
55449134899
-
The medical treatment of obsessive-compulsive disorder and anxiety
-
Bandelow B (2008). The medical treatment of obsessive-compulsive disorder and anxiety. CNS Spectr 13:37-46.
-
(2008)
CNS Spectr
, vol.13
, pp. 37-46
-
-
Bandelow, B.1
-
5
-
-
24644466126
-
The AGNP-TDM Expert Group Consensus Guidelines: Focus on therapeutic monitoring of antidepressants
-
Baumann P, Ulrich S, Eckermann G, Gerlach M, Kuss HJ, Laux G, et al. (2005). Arbeitsgemeinschaft fur neuropsychopharmakologie und pharmakopsyhiatrie-therapeutic drug monitoring group. The AGNP-TDM expert group consensus guidelines: Focus on therapeutic monitoring of antidepressants. Dialogues Clin Neurosci 7:231-247. (Pubitemid 41284688)
-
(2005)
Dialogues in Clinical Neuroscience
, vol.7
, Issue.3
, pp. 231-247
-
-
Baumann, P.1
Ulrich, S.2
Eckermann, G.3
Gerlach, M.4
Kuss, H.-J.5
Laux, G.6
Muller-Oerlinghausen, B.7
Rao, M.L.8
Riederer, P.9
Zernig, G.10
Hiemke, C.11
-
6
-
-
0029852799
-
Minimum effective dose for antidepressants - An obligatory requirement for antidepressant drug evaluation?
-
Benkert O, Szegedi A, Wetzel H (1996). Minimum effective dose for antidepressants-an obligatory requirement for antidepressant drug evaluation? Int Clin Psychopharmacol 11:177-185. (Pubitemid 26361790)
-
(1996)
International Clinical Psychopharmacology
, vol.11
, Issue.3
, pp. 177-185
-
-
Benkert, O.1
Szegedi, A.2
Wetzel, H.3
-
7
-
-
0026786382
-
Clomipramine plasma levels among depressed outpatients in Benin, West Africa: Drug compliance and comparison with Caucasian patients
-
Bertschy G, Vandel S (1992). Clomipramine plasma levels among depressed outpatients in Benin, West Africa: Drug compliance and comparison with Caucasian patients. J Clin Psychopharmacol 12:334-336.
-
(1992)
J Clin Psychopharmacol
, vol.12
, pp. 334-336
-
-
Bertschy, G.1
Vandel, S.2
-
8
-
-
0033817411
-
Relationship between clinical effects, serum drug concentration, and concurrent drug interactions in depressed patients treated with citalopram, fluoxetine, clomipramine, parox-etine or venlafaxine
-
Charlier C, Pinto E, Ansseau M, Plomteux G (2000). Relationship between clinical effects, serum drug concentration, and concurrent drug interactions in depressed patients treated with citalopram, fluoxetine,clomipramine, parox-etine or venlafaxine. Hum Psychopharmacol 15:453-459.
-
(2000)
Hum Psychopharmacol
, vol.15
, pp. 453-459
-
-
Charlier, C.1
Pinto, E.2
Ansseau, M.3
Plomteux, G.4
-
9
-
-
0022063137
-
Plasma levels of clomipramine and its metabolites in hospitalized depressed patients
-
Debray Q, Goyot C, Plaisant O, Pelicier Y, Grenier J (1985). Plasma levels of clomipramine and its metabolites in hospitalized depressed patients. Ann Med Psychology 143:464-474.
-
(1985)
Ann Med Psychology
, vol.143
, pp. 464-474
-
-
Debray, Q.1
Goyot, C.2
Plaisant, O.3
Pelicier, Y.4
Grenier, J.5
-
10
-
-
0020521590
-
Double-blind trial with oral versus intravenous clomipramine in primary depression
-
Faravelli C, Broadhurst AD, Ambonetti A, Ballerini A, De Biase L, La Malfa G, et al. (1983). Double-blind trial with oral versus intravenous clomipramine in primary depression. Biol Psychiatry 18:695-706. (Pubitemid 13067603)
-
(1983)
Biological Psychiatry
, vol.18
, Issue.6
, pp. 695-706
-
-
Faravelli, C.1
Broadhurst, A.D.2
Ambonetti, A.3
-
11
-
-
0021368437
-
Plasma levels and clinical response during treatment with clomipramine
-
DOI 10.1016/0165-0327(84)90011-9
-
Faravelli C, Ballerini A, Ambonetti A, Broadhurst AD, Das M (1984). Plasma levels and clinical response during treatment with clomipramine. J Affect Disord 6:95-107. (Pubitemid 14158976)
-
(1984)
Journal of Affective Disorders
, vol.6
, Issue.1
, pp. 95-107
-
-
Faravelli, C.1
Ballerini, A.2
Ambonetti, A.3
-
12
-
-
15244351436
-
Evidence-based pharmacotherapy of obsessive-compulsive disorder
-
DOI 10.1017/S1461145704004675
-
Fineberg NA, Gale TM (2005). Evidence-based pharmacotherapy of obsessive-compulsive disorder. Int J Neuropsychopharmacol 8:107-129. (Pubitemid 40388819)
-
(2005)
International Journal of Neuropsychopharmacology
, vol.8
, Issue.1
, pp. 107-129
-
-
Fineberg, N.A.1
Gale, T.M.2
-
13
-
-
0004085199
-
-
New York, NY: Biometrics Research, New York State Psychiatric Institute
-
First MB, Spitzer RL, Gibbon M, Williams JBW (1997). Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition (SCID-I P, Version 20, 4 97 revision). New York, NY: Biometrics Research, New York State Psychiatric Institute.
-
(1997)
Structured Clinical Interview for DSM-IV Axis i Disorders-Patient Edition (SCID-i P, Version 20, 4 97 Revision)
-
-
First, M.B.1
Spitzer, R.L.2
Gibbon, M.3
Jbw, W.4
-
14
-
-
0021972864
-
Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study
-
Flament MF, Rapoport JL, Berg CJ, Sceery W, Kilts C, Mellström B, et al. (1985). Clomipramine treatment of childhood obsessive-compulsive disorder: A double-blind controlled study. Arch Gen Psychiatry 42:977-983. (Pubitemid 15245091)
-
(1985)
Archives of General Psychiatry
, vol.42
, Issue.10
, pp. 977-983
-
-
Flament, M.F.1
Rapoport, J.L.2
Berg, C.J.3
-
15
-
-
0024465894
-
The yale-brown obsessive compulsive scale. II. Validity
-
Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, et al. (1989a). The Yale-Brown Obsessive Compulsive Scale. II. Validity. Arch Gen Psychiatry 46:1012-1016. (Pubitemid 19278230)
-
(1989)
Archives of General Psychiatry
, vol.46
, Issue.11
, pp. 1012-1016
-
-
Goodman, W.K.1
Price, L.H.2
Rasmussen, S.A.3
Mazure, C.4
Delgado, P.5
Heninger, G.R.6
Charney, D.S.7
-
16
-
-
0024435153
-
The Yale-Brown Obsessive Compulsive Scale. I. Development, use and reliability
-
Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, et al. (1989b). The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 46:1006-1011. (Pubitemid 19278229)
-
(1989)
Archives of General Psychiatry
, vol.46
, Issue.11
, pp. 1006-1011
-
-
Goodman, W.K.1
Price, L.H.2
Rasmussen, S.A.3
Mazure, C.4
Fleischmann, R.L.5
Hill, C.L.6
Heninger, G.R.7
Charney, D.S.8
-
18
-
-
41049118341
-
Therapeutic drug monitoring in neuropsychopharmacology: Does it hold its promises?
-
DOI 10.1007/s00406-007-1005-y
-
Hiemke C (2008). Therapeutic drug monitoring in neuropsychopharma-cology: Does it hold its promises? Eur Arch Psychiatry Clin Neurosci 258: 21-27. (Pubitemid 351421448)
-
(2008)
European Archives of Psychiatry and Clinical Neuroscience
, vol.258
, Issue.SUPPL. 1
, pp. 21-27
-
-
Hiemke, C.1
-
19
-
-
0020582680
-
Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline
-
Insel TR, Murphy DL, Cohen RM, Alterman I, Kilts C, Linnoila M (1983). Obsessive-compulsive disorder: A double-blind trial of clomipramine and clorgyline. Arch Gen Psychiatry 40:605-612. (Pubitemid 13094927)
-
(1983)
Archives of General Psychiatry
, vol.40
, Issue.6
, pp. 605-612
-
-
Insel, T.R.1
Murphy, D.L.2
Cohen, R.M.3
-
21
-
-
0023898079
-
Clomipramine in obsessive-compulsive ritualisers treated with exposure therapy: Relations between dose, plasma levels, outcome and side effects
-
Kasvikis Y, Marks IM (1988). Clomipramine in obsessive-compulsive ritualisers treated with exposure therapy: Relations between dose, plasma levels, outcome and side effects. Psychopharmacology 95:113-118.
-
(1988)
Psychopharmacology
, vol.95
, pp. 113-118
-
-
Kasvikis, Y.1
Marks, I.M.2
-
22
-
-
0028306616
-
Clomipramine in the elderly: Tolerance and plasma levels
-
Kunik ME, Pollock BG, Perel JM, Altieri L (1994). Clomipramine in the elderly: Tolerance and plasma levels. J Geriatr Psychiatry Neurol 7:139-143. (Pubitemid 24215105)
-
(1994)
Journal of Geriatric Psychiatry and Neurology
, vol.7
, Issue.3
, pp. 139-143
-
-
Kunik, M.E.1
Pollock, B.G.2
Perel, J.M.3
Altieri, L.4
-
23
-
-
0019168588
-
Clomipramine and doxepin in depressive neurosis. Plasma levels and therapeutic response
-
Linnoila M, Seppala T, Mattila MJ, Vihko R, Pakarinen A, Skinner T III (1980). Clomipramine and doxepin in depressive neurosis: Plasma levels and therapeutic response. Arch Gen Psychiatry 37:1295-1299. (Pubitemid 11241585)
-
(1980)
Archives of General Psychiatry
, vol.37
, Issue.11
, pp. 1295-1299
-
-
Linnoila, M.1
Seppala, T.2
Mattila, M.J.3
-
24
-
-
76449087603
-
Treatment strategies for obsessive-compulsive disorder
-
Marazziti D, Consoli G (2010). Treatment strategies for obsessive-compulsive disorder. Expert Opin Pharmacother 11:331-343.
-
(2010)
Expert Opin Pharmacother
, vol.11
, pp. 331-343
-
-
Marazziti, D.1
Consoli, G.2
-
25
-
-
77957969756
-
Past, present and future drugs for the treatment of obsessive-compulsive disorder
-
Marazziti D, Consoli G, Baroni S, Catena Dell'Osso M (2010). Past, present and future drugs for the treatment of obsessive-compulsive disorder. Curr Med Chem 17:3410-3421.
-
(2010)
Curr Med Chem
, vol.17
, pp. 3410-3421
-
-
Marazziti, D.1
Consoli, G.2
Baroni, S.3
Catena Dell'Osso, M.4
-
26
-
-
0033035883
-
Serum levels of clomipramine and desmethylclomipramine and clinical improvement in panic disorder
-
Marcourakis T, Gorenstein C, Ramos RT, da Motta Singer J (1999). Serum levels of clomipramine and desmethylclomipramine and clinical improvement in panic disorder. J Psychopharmacol 13:40-44. (Pubitemid 29141274)
-
(1999)
Journal of Psychopharmacology
, vol.13
, Issue.1
, pp. 40-44
-
-
Marcourakis, T.1
Gorenstein, C.2
Ramos, R.T.3
Da Motta Singer, J.4
-
27
-
-
0024996123
-
The relationship of plasma clomipramine and n-desmethylclomipramine to response in obsessive-compulsive disorder
-
Mavissakalian M, Jones B, Olson S, Perel JM (1990a). The relationship of plasma clomipramine and N-desmethylclomipramine to response in obsessive-compulsive disorder. Psychopharmacol Bull 26:119-122. (Pubitemid 20322257)
-
(1990)
Psychopharmacology Bulletin
, vol.26
, Issue.1
, pp. 119-122
-
-
Mavissakalian, M.1
Jones, B.2
Olson, S.3
Perel, J.M.4
-
28
-
-
0025108090
-
Clomipramine in obsessive-compulsive disorder: Clinical response and plasma levels
-
Mavissakalian M, Jones B, Olson S, Perel JM (1990b). Clomipramine in obsessive-compulsive disorder: Clinical response and plasma levels. J Clin Psychopharmacol 10:261-268. (Pubitemid 20319179)
-
(1990)
Journal of Clinical Psychopharmacology
, vol.10
, Issue.4
, pp. 261-268
-
-
Mavissakalian, M.R.1
Jones, B.2
Olson, S.3
Perel, J.M.4
-
29
-
-
0034918693
-
S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine
-
Millan MJ, Gobert A, Lejune F, Newman-Tancredi A, Rivet JM, Auclair A, et al. (2001). S33005, a novel ligand at both serotonin and norepinephrine transporters: I: Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipra-mine. J Pharmacol Exp Ther 298:565-580. (Pubitemid 32673407)
-
(2001)
Journal of Pharmacology and Experimental Therapeutics
, vol.298
, Issue.2
, pp. 565-580
-
-
Millan, M.J.1
Gobert, A.2
Lejeune, F.3
Newman-Tancredi, A.4
Rivet, J.-M.5
Auclair, A.6
Peglion, J.-L.7
-
30
-
-
0027481384
-
Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs
-
Monsma FJ (1993). Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol Pharmacol 43:327.
-
(1993)
Mol Pharmacol
, vol.43
, pp. 327
-
-
Monsma, F.J.1
-
31
-
-
0018818487
-
Plasma concentration of clomipramine and desmethylclomipramine and clinical response in depressed patients
-
Montgomery SA, McAuley R, Montgomery DB, Dawling S, Braithwaite RA (1980). Plasma concentration of clomipramine and desmethylclomipramine and clinical response in depressed patients. Postgrad Med J 56:130-133. (Pubitemid 10119402)
-
(1980)
Postgraduate Medical Journal
, vol.56
, Issue.SUPPL. 1
, pp. 130-133
-
-
Montgomery, S.A.1
McAuley, R.2
Montgomery, D.B.3
-
32
-
-
0027131435
-
Clinical significance of plasma levels of clomipramine, its hydroxylated and desmethylated metabolites: Prediction of clinical outcome in mood disorders using discriminant analysis of therapeutic drug monitoring data
-
DOI 10.1016/0165-0327(93)90017-E
-
Noguchi T, Shimoda K, Takahashi S (1993). Clinical significance of plasma levels of clomipramine, its hydroxylated and desmethylated metabolites: Prediction of clinical outcome in mood disorders using discriminant analysis of therapeutic drug monitoring data. J Affect Disord 29:267-279. (Pubitemid 24003833)
-
(1993)
Journal of Affective Disorders
, vol.29
, Issue.4
, pp. 267-279
-
-
Noguchi, T.1
Shimoda, K.2
Takahashi, S.3
-
33
-
-
0034037815
-
Simultaneous plasma level analysis of clomipramine, N- desmethylclomipramine, and fluvoxamine by reversed-phase liquid chromatography
-
DOI 10.1097/00007691-200004000-00009
-
Palego L, Marazziti D, Biondi L, Giannaccini G, Sarno N, Armani A, et al. (2000). Simultaneous plasma level analysis of clomipramine, N-desmethylclomipra-mine, and fluvoxamine by reversed-phase liquid chromatography. Ther Drug Monit 22:190-194. (Pubitemid 30196824)
-
(2000)
Therapeutic Drug Monitoring
, vol.22
, Issue.2
, pp. 190-194
-
-
Palego, L.1
Marazziti, D.2
Biondi, L.3
Giannaccini, G.4
Sarno, N.5
Armani, A.6
Lucacchini, A.7
Cassano, G.B.8
Dell'Osso, L.9
-
34
-
-
0023241871
-
CLOMIPRAMINE ET DEMETHYLCLOMIPRAMINE. CORRELATION TAUX PLASMATIQUES/EFFICACITE CHEZ 24 DEPRIMES
-
Pascalis G, Wargny E, Lamiable D, Havet JM (1987). Clomipramine and demethylclomipramine: Correlation of plasma levels and efficacy in 24 depressive patients. Encephale 13:239-244. (Pubitemid 17141235)
-
(1987)
Encephale
, vol.13
, Issue.4
, pp. 239-244
-
-
Pascalis, G.1
Wargny, E.2
Lamiable, D.3
Havet, J.M.4
-
35
-
-
0028093608
-
Tricyclic antidepressant concentrations in plasma: An estimate of their sensitivity and specificity as a predictor of response
-
Perry PJ, Zeilmann C, Arndt S (1994). Tricyclic antidepressant concentrations in plasma: An estimate of their sensitivity and specificity as a predictor of response. J Clin Psychopharmacol 14:230-240. (Pubitemid 24254714)
-
(1994)
Journal of Clinical Psychopharmacology
, vol.14
, Issue.4
, pp. 230-240
-
-
Perry, P.J.1
Zeilmann, C.2
Arndt, S.3
-
36
-
-
0037024144
-
Simultaneous determination of clomipramine and its desmethyl and hydroxy metabolites in plasma of patients by high-performance liquid chromatography after solid-phase extraction
-
DOI 10.1016/S1570-0232(02)00089-2, PII S1570023202000892
-
Pirola R, Mundo E, Bellodi L, Bareggi SR (2002). Simultaneous determination of clomipramine and its desmethyl and hydroxy metabolites in plasma of patients by high-performance liquid chromatography after solid-phase extraction. J Chromatogr B Analyt Technol Biomed Life Sci 5:205-210. (Pubitemid 34499566)
-
(2002)
Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
, vol.772
, Issue.2
, pp. 205-210
-
-
Pirola, R.1
Mundo, E.2
Bellodi, L.3
Bareggi, S.R.4
-
37
-
-
0024342790
-
Tricyclic antidepressants: The whys and hows of therapeutic drug monitoring
-
Preskorn SH (1989). Tricyclic antidepressants: The whys and hows of therapeutic drug monitoring. J Clin Psychiatry 50:34-46.
-
(1989)
J Clin Psychiatry
, vol.50
, pp. 34-46
-
-
Preskorn, S.H.1
-
38
-
-
0025779099
-
Therapeutic drug monitoring for antidepressants: Efficacy, safety, and cost effectiveness
-
Preskorn SH, Fast GA (1991). Therapeutic drug monitoring for antidepressants: Efficacy, safety, and cost effectiveness. J Clin Psychiatry 52:23-33.
-
(1991)
J Clin Psychiatry
, vol.52
, pp. 23-33
-
-
Preskorn, S.H.1
Fast, G.A.2
-
39
-
-
37349026204
-
High-dose escitalopram for the treatment of obsessive-compulsive disorder
-
DOI 10.1097/YIC.0b013e3282f0f0c5, PII 0000485020080100000007
-
Rabinowitz I, Baruch Y, Barak Y (2008). High-dose escitalopram for the treatment of obsessive-compulsive disorder. Int Clin Psychopharmacol 23:49-53. (Pubitemid 350294870)
-
(2008)
International Clinical Psychopharmacology
, vol.23
, Issue.1
, pp. 49-53
-
-
Rabinowitz, I.1
Baruch, Y.2
Barak, Y.3
-
40
-
-
0018412441
-
Plasma levels of tricyclic antidepressants and clinical efficacy: Review of the literature. Part II
-
Risch SC, Huey LY, Janowsky DS (1979). Plasma levels of tricyclic antidepres-sants and clinical efficacy: Review of the literature-part II. J Clin Psychiatry 40:58-69. (Pubitemid 9107119)
-
(1979)
Journal of Clinical Psychiatry
, vol.40
, Issue.2
, pp. 58-69
-
-
Risch, S.C.1
Huey, L.Y.2
Janowsky, D.S.3
-
41
-
-
0027462948
-
Selective serotonin reuptake inhibitors: Meta-analysis of efficacy and acceptability
-
Song F, Freemantle N, Sheldon TA, House A, Watson P, Long A, et al. (1993). Selective serotonin reuptake inhibitors: Meta-analysis of efficacy and acceptability. Br Med J 13:683-687. (Pubitemid 23070230)
-
(1993)
British Medical Journal
, vol.306
, Issue.6879
, pp. 683-687
-
-
Song, F.1
Freemantle, N.2
Sheldon, T.A.3
House, A.4
Watson, P.5
Long, A.6
Mason, J.7
-
42
-
-
0028905968
-
Meta-analysis of pharmacotherapy trials for obsessive-compulsive disorder
-
Stein DJ, Spadaccini E, Hollander E (1995). Meta-analysis of pharmacotherapy trials for obsessive-compulsive disorder. Int Clin Psychopharmacol 10:11-18.
-
(1995)
Int Clin Psychopharmacol
, vol.10
, pp. 11-18
-
-
Stein, D.J.1
Spadaccini, E.2
Hollander, E.3
-
44
-
-
0017652982
-
A preliminary report on clinical response and plasma levels of clomipramine and desmethylclomipramine in obsessive-compulsive neurosis
-
Stern RS, Cobb JP, Marks IM, Jones RB, Luscombe DK (1977). A preliminary report on clinical response and plasma levels of clomipramine and desmethylclomipramine in obsessive-compulsive neurosis. Postgrad Med J 53:97-103. (Pubitemid 8234907)
-
(1977)
Postgraduate Medical Journal
, vol.53
, Issue.SUPPL. 4
, pp. 97-103
-
-
Stern, R.S.1
Cobb, J.P.2
Marks, I.M.3
-
45
-
-
0018861599
-
Clomipramine and exposure for compulsive rituals: II. Plasma levels, side effects and outcome
-
Stern RS, Marks IM, Mawson D, Luscombe DK (1980). Clomipramine and exposure for compulsive rituals: II. Plasma levels, side effects and outcome. Br J Psychiatry 136:161-166. (Pubitemid 10183251)
-
(1980)
British Journal of Psychiatry
, vol.136
, Issue.2
, pp. 161-166
-
-
Stern, R.S.1
Marks, I.M.2
Mawson, D.3
Luscombe, D.K.4
-
46
-
-
79959922915
-
NET occupancy by clomipramine and its active metabolite, desmethylclomipramine, in non-human primate in vivo
-
Takano A, Nag S, Gulyas B, Halldin C, Farde L (2011). NET occupancy by clomipramine and its active metabolite, desmethylclomipramine, in non-human primate in vivo. Psychopharmacol 216:279-286.
-
(2011)
Psychopharmacol
, vol.216
, pp. 279-286
-
-
Takano, A.1
Nag, S.2
Gulyas, B.3
Halldin, C.4
Farde, L.5
-
47
-
-
0019160802
-
Clomipramine treatment of obsessive-compulsive disorder. II. Biochemical aspects
-
Thorén P, Asberg M, Bertilsson L, Mellström B, Sjöqvist F, Träskman L (1980). Clomipramine treatment of obsessive-compulsive disorder. II. Biochemical aspects. Arch Gen Psychiatry 37:1289-1294.
-
(1980)
Arch Gen Psychiatry
, vol.37
, pp. 1289-1294
-
-
Thorén, P.1
Asberg, M.2
Bertilsson, L.3
Mellström, B.4
Sjöqvist, F.5
Träskman, L.6
-
48
-
-
0025572195
-
Tricyclic antidepressant plasma level monitoring: Intraindividual variability in everyday practice
-
Vandel S, Bertschy G, Nezeloff S, Bonin B, Volmat R (1990). Tricyclic antidepressant plasma level monitoring: Intraindividual variability in everyday practice. Eur J Clin Pharmacol 39:611-612.
-
(1990)
Eur J Clin Pharmacol
, vol.39
, pp. 611-612
-
-
Vandel, S.1
Bertschy, G.2
Nezeloff, S.3
Bonin, B.4
Volmat, R.5
-
49
-
-
0026326022
-
Use of plasma level monitoring of antidepressants in clinical practice: Towards an analysis of clinical utility
-
Vuille F, Amey M, Baumann P (1991). Use of plasma level monitoring of antidepressants in clinical practice: Towards an analysis of clinical utility. Pharmacopsychiatry 24:190-195.
-
(1991)
Pharmacopsychiatry
, vol.24
, pp. 190-195
-
-
Vuille, F.1
Amey, M.2
Baumann, P.3
-
50
-
-
0023019568
-
Plasma levels of clomipramine and declomipramine in patients with depression: A study of its correlation with therapeutic efficacy
-
Wargny E, Lamiable D, Havet JM, Denis J, Millart H, Choisy H, et al. (1986). Plasma levels of clomipramine and declomipramine in patients with depression: A study of its correlation with therapeutic efficacy. Ann Med Psychol 144:396-406.
-
(1986)
Ann Med Psychol
, vol.144
, pp. 396-406
-
-
Wargny, E.1
Lamiable, D.2
Havet, J.M.3
Denis, J.4
Millart, H.5
Choisy, H.6
|